Shawn Curtiss

Title: Innovations by Shawn Curtiss in Drug Diversion Detection

Introduction

Shawn Curtiss is an accomplished inventor based in O'Fallon, MO (US). He has made significant contributions to the field of drug diversion detection, holding 2 patents that focus on improving the management of controlled substances in medical facilities. His work aims to enhance the safety and integrity of drug management systems.

Latest Patents

Shawn's latest patents include a method and apparatus for detecting suspicious activities surrounding the management of controlled substances. This innovative approach involves flagging activities that may indicate the diversion of controlled drugs for further review. The detection process utilizes application layer network packets related to controlled substances on the medical facility network. By identifying the physical location of the packet's origin and processing these packets with a rules engine and machine learning-generated rules, the system can determine if the circumstances suggest potential diversion of controlled substances.

Career Highlights

Shawn Curtiss is currently employed at Bottomline Technologies Limited, where he continues to develop solutions that address critical issues in drug management. His expertise in network security and machine learning has positioned him as a key player in the fight against drug diversion in healthcare settings.

Collaborations

Shawn collaborates with talented professionals in his field, including Mark Benoit and Benjamin J. Smith. Their combined efforts contribute to the advancement of technologies aimed at safeguarding controlled substances.

Conclusion

Shawn Curtiss's innovative work in drug diversion detection exemplifies the importance of technology in enhancing healthcare safety. His patents reflect a commitment to improving the management of controlled substances, ultimately benefiting medical facilities and patients alike.